The results of previous epidemiologic research on the possible association
between maternal smoking during pregnancy and risk of oral clefts in offspr
ing have been inconsistent. This may be due in part to methodological limit
ations, including imprecise measurement of tobacco use, failure to consider
etiologic heterogeneity among types of oral clefts, and confounding. This
analysis, based on a large case-control study, further evaluated the effect
of first trimester maternal smoking on oral facial cleft risk by examining
the dose-response relationship according to specific cleft type and accord
ing to whether or not additional malformations were present. A number of fa
ctors, including dietary and supplemental folate intake and family history
of clefts, were evaluated as potential confounders and effect modifiers. Da
ta on 3,774 mothers interviewed between 1976 and 1992 by the Slone Epidemio
logy Unit Birth Defects Study were used. Study subjects were actively ascer
tained from sites in areas around Boston, Massachusetts and Philadelphia, P
ennsylvania; the state of Iowa; and southeastern Ontario, Canada. Cases wer
e infants with isolated defects-cleft lip alone (n = 334), cleft lip and pa
late (n = 494), or cleft palate alone (n = 244)-and infants with clefts plu
s (+) additional malformations: cleft lip+ (n = 58), cleft lip and palate(n = 140), or cleft palate+ (n = 209). Controls were infants with defects o
ther than clefts, excluding defects possibly associated with maternal cigar
ette use. There were no associations with maternal smoking for any oral cle
ft group, except for a positive dose response among infants with cleft lip
and palate+ (for light smokers, odds ratio (OR) = 1.09 (95% confidence inte
rval (CI): 0.6, 1.9); for moderate smokers, OR = 1.84 (95% CI: 1.2, 2.9); a
nd for heavy smokers, OR = 1.85 (95% CI: 1.0, 3.5), relative to nonsmokers)
. This finding may be related to the additional malformations rather than t
o the cleft itself.